← Back to Search

Virus Vaccine

BNT162b2 vaccine for Coronavirus

Phase 3
Waitlist Available
Led By Giselle Guerra, MD
Research Sponsored by Giselle Guerra
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 month (post third dose)
Awards & highlights

Study Summary

This trial will test if a booster dose of a certain type of vaccine can help protect people who have had organ transplants from coronavirus disease.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 month (post third dose)
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 month (post third dose) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Participants Who Tested Positive for IgG Antibodies to the Anti-spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Secondary outcome measures
Number of Participants With COVID-19 Symptom Severity as Measured by the WHO Scale
Number of Participants With Vaccine-related Adverse Events
Proportion of Participants With a Positive COVID-19 Test

Trial Design

2Treatment groups
Experimental Treatment
Group I: JNJ-78436735 vaccine GroupExperimental Treatment1 Intervention
Participants in this arm will receive one booster dose of the JNJ-78436735
Group II: BNT162b2 vaccine GroupExperimental Treatment1 Intervention
Participants in this arm will receive one booster dose of the BNT162b2.

Find a Location

Who is running the clinical trial?

Giselle GuerraLead Sponsor
Giselle Guerra, MDPrincipal InvestigatorUniversity of Miami
1 Previous Clinical Trials
8 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Florida
How old are they?
65+
18 - 65
What site did they apply to?
University of Miami
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
Recent research and studies
clinicaltrials.govStudy
COVID-19 3rd Dose Vaccine in Transplant Patients
Giselle Guerra 2021. "COVID-19 3rd Dose Vaccine in Transplant Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05047640.
~16 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top